Challenges and opportunities for drug delivery to the posterior of the eye
Author:
Funder
National Eye Institute
Publisher
Elsevier BV
Subject
Drug Discovery,Pharmacology
Reference67 articles.
1. Current treatment limitations in age-related macular degeneration and future approaches based on cell therapy and tissue engineering;Fernández-Robredo;J. Ophthalmol.,2014
2. Present and possible therapies for age-related macular degeneration;Khan;ISRN Ophthalmol.,2014
3. New treatments for diabetic retinopathy;Das;Diabetes Obes. Metab.,2015
4. Diabetic retinopathy: current understanding, mechanisms, and treatment strategies;Duh;JCI Insight,2017
5. A review on recent drug delivery systems for posterior segment of eye;Nayak;Biomed. Pharmacother.,2018
Cited by 69 articles. 订阅此论文施引文献 订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献
1. Nanomedicine in glaucoma treatment; Current challenges and future perspectives;Materials Today Bio;2024-10
2. Unlocking ocular therapy: Harnessing the power of non-coding RNAs;Journal of Drug Delivery Science and Technology;2024-09
3. Light‐Activated Anti‐Vascular Combination Therapy against Choroidal Neovascularization;Advanced Science;2024-08-29
4. Injectable Smart Hydrogels for the Treatment of Microbial Infections;Injectable Smart Hydrogels for Biomedical Applications;2024-07-19
5. The Role of Reactive Oxygen Species in Age-Related Macular Degeneration: A Comprehensive Review of Antioxidant Therapies;Biomedicines;2024-07-16
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3